The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 3,074 | 227,717 | SH | SOLE | 227,717 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 5,321 | 156,355 | SH | SOLE | 156,355 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 2,298 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Cytokinetics Incorporated | COM | 23282W605 | 25,670 | 2,177,292 | SH | SOLE | 2,177,292 | 0 | 0 | ||
Fulcrum Therapeutics, Inc. | COM | 359616109 | 11,924 | 998,655 | SH | SOLE | 998,655 | 0 | 0 | ||
Insmed Incorporated | COM | 457669307 | 10,874 | 678,322 | SH | SOLE | 678,322 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM | G5269C101 | 1,006 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
Kura Oncology, Inc. | COM | 50127T109 | 925 | 93,000 | SH | SOLE | 93,000 | 0 | 0 | ||
Myokardia, Inc. | COM | 62857M105 | 14,411 | 307,400 | SH | SOLE | 307,400 | 0 | 0 | ||
uniQure N.V. | SHS | N90064101 | 905 | 19,082 | SH | SOLE | 19,082 | 0 | 0 | ||
Voyager Therapeutics, Inc. | COM | 92915B106 | 4,728 | 516,751 | SH | SOLE | 516,751 | 0 | 0 |